Literature DB >> 15893739

Regulation of myeloid leukemia factor-1 interacting protein (MLF1IP) expression in glioblastoma.

Silva H Hanissian1, Bin Teng, Umar Akbar, Zorica Janjetovic, Qihong Zhou, Christopher Duntsch, Jon H Robertson.   

Abstract

The myelodysplasia/myeloid leukemia factor 1-interacting protein MLF1IP is a novel gene which encodes for a putative transcriptional repressor. It is localized to human chromosome 4q35.1 and is expressed in both the nuclei and cytoplasm of cells. Northern and Western blot analyses have revealed MLF1IP to be present at very low amounts in normal brain tissues, whereas a number of human and rat glioblastoma (GBM) cell lines demonstrated a high level expression of the MLF1IP protein. Immunohistochemical analysis of rat F98 and C6 GBM tumor models showed that MLF1IP was highly expressed in the tumor core where it was co-localized with MLF1 and nestin. Moreover, MLF1IP expression was elevated in the contralateral brain where no tumor cells were detected. These observations, together with previous data demonstrating a role for MLF1IP in erythroleukemias, suggest a possible function for this protein in glioma pathogenesis and potentially in other types of malignancies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893739     DOI: 10.1016/j.brainres.2005.04.017

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

Review 1.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Authors:  Rolf F Barth; Balveen Kaur
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

2.  Centromere protein U facilitates metastasis of ovarian cancer cells by targeting high mobility group box 2 expression.

Authors:  Hongjuan Li; Hui Zhang; Yali Wang
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

3.  The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.

Authors:  Shuang-Yan Lin; Yan-Bo Lv; Gen-Xiang Mao; Xu-Jiao Chen; Fang Peng
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

4.  20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.

Authors:  Zorica Janjetovic; Robert C Tuckey; Minh N Nguyen; Edwin M Thorpe; Andrzej T Slominski
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

5.  Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles.

Authors:  Gabriela D A Guardia; Bruna R Correa; Patricia Rosa Araujo; Mei Qiao; Suzanne Burns; Luiz O F Penalva; Pedro A F Galante
Journal:  NPJ Genom Med       Date:  2020-01-16       Impact factor: 8.617

6.  A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression.

Authors:  Ashley A Smith; Yen-Tsung Huang; Melissa Eliot; E Andres Houseman; Carmen J Marsit; John K Wiencke; Karl T Kelsey
Journal:  Epigenetics       Date:  2014-03-26       Impact factor: 4.528

7.  MLF1 interacting protein: a potential gene therapy target for human prostate cancer?

Authors:  Lei Zhang; Guoqing Ji; Yuzhang Shao; Shaoyi Qiao; Yuming Jing; Rongliang Qin; Huiming Sun; Chen Shao
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

8.  20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.

Authors:  Blazej Zbytek; Zorica Janjetovic; Robert C Tuckey; Michal A Zmijewski; Trevor W Sweatman; Emily Jones; Minh N Nguyen; Andrzej T Slominski
Journal:  J Invest Dermatol       Date:  2008-03-27       Impact factor: 8.551

9.  Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.

Authors:  Gideon Y Stein; Nir Yosef; Hadar Reichman; Judith Horev; Adi Laser-Azogui; Angelique Berens; James Resau; Eytan Ruppin; Roded Sharan; Ilan Tsarfaty
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes.

Authors:  Zorica Janjetovic; Michal A Zmijewski; Robert C Tuckey; Damon A DeLeon; Minh N Nguyen; Lawrence M Pfeffer; Andrzej T Slominski
Journal:  PLoS One       Date:  2009-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.